Disc Medicine appoints Jean Franchi as CFO effective Feb 7, 2024; promotes Jonathan Yu to COO

Disc Medicine, Inc.

Jean Franchi appointed CFO, replacing Joanne Bryce who transitions to consulting; effective Feb 7, 2024.
Franchi receives $515k base salary, $75k signing bonus, 40% target bonus; inducement equity: option for 55k shares and RSU for 36,666 shares.
Franchi brings 30+ years experience; previously CFO at Replimune, Merrimack, Dimension Therapeutics, and Genzyme.
Jonathan Yu promoted from Chief Business Officer to COO effective Feb 7, 2024.
Equity inducement awards granted outside the 2021 stock plan per Nasdaq Listing Rule 5635(c)(4).

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jonathan Yu

Chief Operating Officer

IRON · Disc Medicine, Inc.

Effective: 2024-02-07
Filed: February 7, 2024, 6:59 PM ET

On February 7, 2024 (the "Promotion Date"), the Company announced that Jonathan Yu, the Company's previous Chief Business Officer, was promoted to serve as the Company's Chief Operating Officer.

Appointed

Jean M. Franchi

Chief Financial Officer and Treasurer

IRON · Disc Medicine, Inc.

Effective: 2024-02-07
Filed: February 7, 2024, 6:59 PM ET

On February 7, 2024, the Company announced the appointment of Jean M. Franchi as Chief Financial Officer and Treasurer, effective February 7, 2024

Departed

Joanne Bryce

Chief Financial Officer and Treasurer

IRON · Disc Medicine, Inc.

Effective: 2024-02-07
Successor: Jean M. Franchi
Filed: February 7, 2024, 6:59 PM ET

Ms. Franchi succeeds Joanne Bryce, who, as previously announced by the Company, will depart from her role as Chief Financial Officer and Treasurer, effective as of the Effective Date.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan Yu changed role as Chief Operating Officer at Disc Medicine, Inc..

Action: promoted
Role: Chief Operating Officer

Exact text from the filing

On February 7, 2024 (the "Promotion Date"), the Company announced that Jonathan Yu, the Company's previous Chief Business Officer, was promoted to serve as the Company's Chief Operating Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Jean M. Franchi was appointed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..

Action: appointed
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On February 7, 2024, the Company announced the appointment of Jean M. Franchi as Chief Financial Officer and Treasurer, effective February 7, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Joanne Bryce departed as Chief Financial Officer and Treasurer at Disc Medicine, Inc..

Action: departed
Role: Chief Financial Officer and Treasurer

Exact text from the filing

Ms. Franchi succeeds Joanne Bryce, who, as previously announced by the Company, will depart from her role as Chief Financial Officer and Treasurer, effective as of the Effective Date.

View on SEC.gov

Disc Medicine, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-025951

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.